169 related articles for article (PubMed ID: 28939041)
21. Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis.
Licker V; Turck N; Kövari E; Burkhardt K; Côte M; Surini-Demiri M; Lobrinus JA; Sanchez JC; Burkhard PR
Proteomics; 2014 Mar; 14(6):784-94. PubMed ID: 24449343
[TBL] [Abstract][Full Text] [Related]
22. Loss of transketolase promotes the anti-diabetic role of brown adipose tissues.
Ji Y; Liu W; Zhu Y; Li Y; Lu Y; Liu Q; Tong L; Hu L; Xu N; Chen Z; Tian N; Wu L; Zhu L; Tang S; Zhang P; Tong X
J Endocrinol; 2023 Mar; 256(3):. PubMed ID: 36449405
[TBL] [Abstract][Full Text] [Related]
23. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
24. Toki-to protects dopaminergic neurons in the substantia nigra from neurotoxicity of MPTP in mice.
Sakai R; Irie Y; Murata T; Ishige A; Anjiki N; Watanabe K
Phytother Res; 2007 Sep; 21(9):868-73. PubMed ID: 17486689
[TBL] [Abstract][Full Text] [Related]
25. Transketolase of Staphylococcus aureus in the Control of Master Regulators of Stress Response During Infection.
Tan X; Ramond E; Jamet A; Barnier JP; Decaux-Tramoni B; Dupuis M; Euphrasie D; Tros F; Nemazanyy I; Ziveri J; Nassif X; Charbit A; Coureuil M
J Infect Dis; 2019 Nov; 220(12):1967-1976. PubMed ID: 31420648
[TBL] [Abstract][Full Text] [Related]
26. Investigation of Long Non-coding RNA Expression Profiles in the Substantia Nigra of Parkinson's Disease.
Ni Y; Huang H; Chen Y; Cao M; Zhou H; Zhang Y
Cell Mol Neurobiol; 2017 Mar; 37(2):329-338. PubMed ID: 27151187
[TBL] [Abstract][Full Text] [Related]
27. The nuclear translocation of transketolase inhibits the farnesoid receptor expression by promoting the binding of HDAC3 to FXR promoter in hepatocellular carcinoma cell lines.
Li M; Zhang X; Lu Y; Meng S; Quan H; Hou P; Tong P; Chai D; Gao X; Zheng J; Tong X; Bai J
Cell Death Dis; 2020 Jan; 11(1):31. PubMed ID: 31949131
[TBL] [Abstract][Full Text] [Related]
28. Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease.
Licker V; Côte M; Lobrinus JA; Rodrigo N; Kövari E; Hochstrasser DF; Turck N; Sanchez JC; Burkhard PR
J Proteomics; 2012 Aug; 75(15):4656-67. PubMed ID: 22410244
[TBL] [Abstract][Full Text] [Related]
29. Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the α-Ketoglutarate Signaling Pathway.
Tseng CW; Kuo WH; Chan SH; Chan HL; Chang KJ; Wang LH
Cancer Res; 2018 Jun; 78(11):2799-2812. PubMed ID: 29599405
[TBL] [Abstract][Full Text] [Related]
30. Transketolase-like protein 1 (TKTL1) is required for rapid cell growth and full viability of human tumor cells.
Xu X; Zur Hausen A; Coy JF; Löchelt M
Int J Cancer; 2009 Mar; 124(6):1330-7. PubMed ID: 19065656
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
[TBL] [Abstract][Full Text] [Related]
32. PARIS undergoes liquid-liquid phase separation and poly(ADP-ribose)-mediated solidification.
Kang H; Park S; Jo A; Mao X; Kumar M; Park CH; Ahn JY; Lee Y; Choi JY; Lee YS; Dawson VL; Dawson TM; Kam TI; Shin JH
EMBO Rep; 2023 Nov; 24(11):e56166. PubMed ID: 37870275
[TBL] [Abstract][Full Text] [Related]
33. Transketolase promotes MAFLD by limiting inosine-induced mitochondrial activity.
Tong L; Chen Z; Li Y; Wang X; Yang C; Li Y; Zhu Y; Lu Y; Liu Q; Xu N; Shao S; Wu L; Zhang P; Wu G; Wu X; Chen X; Fang J; Jia R; Xu T; Li B; Zheng L; Liu J; Tong X
Cell Metab; 2024 May; 36(5):1013-1029.e5. PubMed ID: 38547864
[TBL] [Abstract][Full Text] [Related]
34. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
36. Upregulation of alphaB-crystallin expression in the substantia nigra of patients with Parkinson's disease.
Liu Y; Zhou Q; Tang M; Fu N; Shao W; Zhang S; Yin Y; Zeng R; Wang X; Hu G; Zhou J
Neurobiol Aging; 2015 Apr; 36(4):1686-1691. PubMed ID: 25683516
[TBL] [Abstract][Full Text] [Related]
37. Transketolase gene expression in the cornea is influenced by environmental factors and developmentally controlled events.
Sax CM; Kays WT; Salamon C; Chervenak MM; Xu YS; Piatigorsky J
Cornea; 2000 Nov; 19(6):833-41. PubMed ID: 11095059
[TBL] [Abstract][Full Text] [Related]
38. [Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].
Wang YS; Zhou JP; Wei ZF; Tian QY; Zhou HX; Zhang YX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1199-202, 1205. PubMed ID: 17715026
[TBL] [Abstract][Full Text] [Related]
39. Integrative genome-wide analysis of dopaminergic neuron-specific PARIS expression in Drosophila dissects recognition of multiple PPAR-γ associated gene regulation.
Yazar V; Kang SU; Ha S; Dawson VL; Dawson TM
Sci Rep; 2021 Nov; 11(1):21500. PubMed ID: 34728675
[TBL] [Abstract][Full Text] [Related]
40. Transketolase is upregulated in metastatic peritoneal implants and promotes ovarian cancer cell proliferation.
Ricciardelli C; Lokman NA; Cheruvu S; Tan IA; Ween MP; Pyragius CE; Ruszkiewicz A; Hoffmann P; Oehler MK
Clin Exp Metastasis; 2015 Jun; 32(5):441-55. PubMed ID: 25895698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
